Andrew Potter, Director and CEO of the Vaccine and Infectious Disease Organization - International Vaccine Centre (VIDO-InterVac) has been elected a Fellow of the Canadian Academy of Health Sciences. Potter has made critical contributions to vaccine research and development and has been instrumental in transferring technology developed at VIDO-InterVac from the lab to the private sector for the benefit of Canadians and the global community. His work has contributed to several world firsts, including the world’s first genetically engineered animal vaccine and the world’s first vaccine to protect food and water against E. coli 0157:H7.
Dr. Andrew Potter is an internationally recognized expert in vaccine development and disease prevention who has made tremendous contributions to the advancement of academic medical research. He is Director and CEO of the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan as well as a Founding Director and former CEO of the Pan-Provincial Vaccine Enterprise (PREVENT), funded by the National Centres of Excellence Program. He is renowned for groundbreaking research into how bacteria cause disease. His research has generated several world firsts in disease prevention and more than 50 patents for human and animal vaccines and therapeutics.